27th IUSTI World Congress
14–17 October 2026 | Prague, Czech Republic
Abstract Submission:
19 April 2026: Abstract Submission Deadline
End of May 2026: Notification of Abstract Acceptance
Registration:
15 June 2026: Early Bird Registration Deadline
IUSTI-Europe Newsletter
New: IUSTI Newsletter March 2026 including an updated European section
IUSTI Newsletter March 2026 (PDF)
IUSTI-World Newsletter with European part
→ IUSTI-Europe Newsletter archive
Dr James Bingham
It is with great sadness that we inform you of the passing of Dr James Bingham, whom many of you will remember as a key figure within IUSTI.
He served the society with great commitment as Treasurer from 1995 to 1999, President Elect from 1999 to 2001, and President from 2001 to 2003. James remained actively engaged with IUSTI well into his seventies and last addressed the Society at the European meeting in 2019.
Our sincere condolences go to his family, friends, and colleagues.
On behalf of IUSTI-Europe
Claudia Heller-Vitouch (Regional Director)
George Sorin Tiplica (Chair of the Council)
IUSTI-Europe Rising Star Scientific Award
IUSTI-Europe is delighted to announce that submissions are now open for the Rising Star Scientific Award - celebrating early-career medical professionals who are making significant contributions to sexually transmitted infection (STI) research and public health with a clear European focus.
This prestigious award includes:
- € 1000 monetary prize
- Registration for the Autumn IUSTI-Europe Congress
- An invitation to deliver a lecture at the meeting
Full eligibility criteria include:
- A recognised medical qualification
- Being within 10 years of receiving the medical degree (with allowances for career interruptions)
- Demonstrated scientific excellence, innovation, and European-focused STI work
- Evidence of leadership and engagement with IUSTI Europe activities
The recipient will be selected by the IUSTI-Europe Scientific Committee in March 2026.
Application Deadline: Ended for 2026. The winner will be announced here soon.
IUSTI-Europe Guidelines Board Position Statement on Doxy PEP
IUSTI-Europe Council agreed the attached position statement on use of Doxy PEP for bacterial STI at its meeting on 25 June 2024.
Read more:
IUSTI-Europe Statement on Doxy PEP
IUSTI-Europe Statement on HIV Pre-exposure Prophylaxis Provision – Key Steps for Clinicians
Europe and near Asia are facing different problems with controlling the HIV epidemic. In making this statement IUSTI- Europe wishes to identify the important steps governments, agencies, healthcare providers and individuals can take to promote the availability, accessibility and take up of Pre-exposure prophylaxis (PrEP) against HIV. Although these have been clearly articulated in the WHO PrEP Guidance and the review of PrEP provision that the ECDC has recently issued we consider it important that clinicians recognise the urgency with which this needs to be undertaken.
Read more:
IUSTI-Europe Statement (English)